subscribeSubscribe
Prinston`s Generic Candesartan Cilexetil Receives Approval in the U.S.

Prinston`s Generic Candesartan Cilexetil Receives Approval in the U.S.
FDA
24 Aug 2023
Share Share
Enforcement Report - Week of September 22, 2021

Enforcement Report - Week of September 22, 2021
FDA
22 Sep 2021
Share Share
Enforcement Report - Week of April 21, 2021

Enforcement Report - Week of April 21, 2021
FDA
22 Apr 2021
Share Share
AstraZeneca divests Atacand commercial rights to Cheplapharm

AstraZeneca divests Atacand commercial rights to Cheplapharm
PHARMACEUTICAL-TECHNOLOGY
05 Jan 2021
Share Share
Atacand divestment to Cheplapharm in more than 70 countries completed

Atacand divestment to Cheplapharm in more than 70 countries completed
PRESS RELEASE
04 Jan 2021
Share Share
Enforcement Report - Week of January 23, 2019

Enforcement Report - Week of January 23, 2019
FDA
23 Jan 2019
Share Share
43 popular heart drugs found to contain carcinogens in Taiwan

43 popular heart drugs found to contain carcinogens in Taiwan
Ryan Drillsma TAIWAN NEWS
19 Jan 2019
Share Share
FDA presents interim limits of nitrosamines in currently marketed ARBs

FDA presents interim limits of nitrosamines in currently marketed ARBs
FDA
21 Dec 2018
Share Share
Alembic Pharms` Generic Candesartan Cilexetil Receives Approval in US

Alembic Pharms` Generic Candesartan Cilexetil Receives Approval in US
FDA
04 Dec 2018
Share Share
Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity

Valsartan from Mylan laboratories in India can no longer be used in EU medicines due to NDEA impurity
EMA
20 Nov 2018
Share Share